John Flygare
Head of ADC Discovery Eli Lilly
Seminars
Wednesday 5th November 2025
The Way Forward: What’s the New Path to the Next-Generation of ADCs?
12:30 pm
- Understanding how to migrate from non-selective ADC payloads
- Debating the right properties for a next generation payload and linker: Can (or should?) any small molecule therapeutic be developed into an ADC?
- Debating the right strategy for dual-payload ADCs
- Understanding ADC toxicity and developability for next-generation conjugates
